Inflammatory Choroidal Neovascularization in Pediatric Uveitis: A Case Series
Klinische Monatsblätter für Augenheilkunde · 01.04.2025 · 242 (04) · 466-470
DOI: 10.1055/a-2467-1804 ↗Kurz gefasst
Fallbericht in der Zeitschrift Klinische Monatsblätter für Augenheilkunde, erschienen am 01.04.2025. Verfasst von Amandine Gauderon und 5 weiteren Autor:innen. Beteiligte Einrichtung: Jules-Gonin Eye Hospital, FAA, Uveitis Clinic, Department of Ophthalmology, University of Lausanne, Switzerland. Hauptthemen laut MEDLINE: Choroidal Neovascularization, Uveitis. Die Arbeit nennt 12 Literaturangaben.
Abstract (Originalsprache)
Background
The aim of our study is to describe clinical features, therapy, and outcome of children with inflammatory choroidal neovascularization (CNV).
Methods
Retrospective case series of children seen at the Jules-Gonin Eye Hospital between 2000 and 2024 with macular choroidal neovascularisation secondary to ocular inflammation.
Results
Four children (one male, three females) developed a retro-foveolar neovascular membrane after a median time of 2.5 months (range 1 – 16 months) following uveitis onset. The median age at presentation was 12 years (range 5 – 12 years). The CNV presentation was unilateral in all four cases, with three patients having posterior uveitis and one panuveitis. Two patients had idiopathic bilateral granulomatous uveitis while the other two had suspected toxoplasmosis chorioretinitis. Idiopathic cases were treated with oral steroids, with one patient being additionally treated with adalimumab. Toxoplasmosis cases were managed with antibiotics and oral steroids. CNV treatment involved a single anti-VEGF injection in two cases, six injections in one case, and no injection in one case due to CNV inactivity. Median follow-up period was 4.25 years (range 0.75 to 11 years) and the median final best-corrected visual acuity was 0.9 (range 0.6 – 1.25). No recurrence of CNV was observed, despite uveitis reactivation in two cases.
Conclusion
Anti-VEGF therapy is safe even in young children with minimal injections required to control the disease. Treating the underlying cause of uveitis with appropriate therapy is also crucial.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Jules-Gonin Eye Hospital, FAA, Uveitis Clinic, Department of Ophthalmology, University of Lausanne, Switzerland.
- Jules-Gonin Eye Hospital, FAA, Medical Retina, Department of Ophthalmology, University of Lausanne, Switzerland.
- Unit of Pediatric Rheumatology, Immunology and Allergology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
ORCID-Profile: Amandine Gauderon, Chiara Eandi, Florence Hoogewoud, Katerina Theodoropoulou, Yan Guex-Crosier
Zitieren
APA
Gauderon, A., Eandi, C., Koryllou, A., Hoogewoud, F., Theodoropoulou, K., & Guex-Crosier, Y. (2025). Inflammatory Choroidal Neovascularization in Pediatric Uveitis: A Case Series. Klinische Monatsblätter für Augenheilkunde, 242(04), 466-470. https://doi.org/10.1055/a-2467-1804
Vancouver
Gauderon A, Eandi C, Koryllou A, Hoogewoud F, Theodoropoulou K, Guex-Crosier Y. Inflammatory Choroidal Neovascularization in Pediatric Uveitis: A Case Series. Klinische Monatsblätter für Augenheilkunde. 2025;242(04):466-470. doi:10.1055/a-2467-1804
BibTeX
@article{Gauderon2025,
author = {Gauderon, Amandine and Eandi, Chiara and Koryllou, Aikaterini and Hoogewoud, Florence and Theodoropoulou, Katerina and Guex-Crosier, Yan},
title = {Inflammatory Choroidal Neovascularization in Pediatric Uveitis: A Case Series},
journal = {Klinische Monatsblätter für Augenheilkunde},
year = {2025},
volume = {242},
number = {04},
pages = {466--470},
doi = {10.1055/a-2467-1804}
}
EUVIMED